Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 4
1958 3
1960 1
1961 7
1962 5
1963 18
1964 8
1965 20
1966 19
1967 19
1968 34
1969 13
1970 24
1971 27
1972 16
1973 24
1974 39
1975 44
1976 34
1977 41
1978 48
1979 56
1980 57
1981 64
1982 89
1983 100
1984 89
1985 101
1986 89
1987 109
1988 117
1989 127
1990 118
1991 141
1992 140
1993 133
1994 131
1995 139
1996 159
1997 155
1998 172
1999 200
2000 238
2001 220
2002 212
2003 211
2004 239
2005 250
2006 291
2007 303
2008 314
2009 342
2010 282
2011 322
2012 343
2013 366
2014 298
2015 305
2016 341
2017 343
2018 325
2019 318
2020 397
2021 472
2022 393
2023 393
2024 380
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,943 results

Results by year

Filters applied: . Clear all
Page 1
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Pápai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D; SOLAR-1 Study Group. André F, et al. Among authors: inoue k. N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904. N Engl J Med. 2019. PMID: 31091374 Clinical Trial.
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
Chan A, Moy B, Mansi J, Ejlertsen B, Holmes FA, Chia S, Iwata H, Gnant M, Loibl S, Barrios CH, Somali I, Smichkoska S, Martinez N, Alonso MG, Link JS, Mayer IA, Cold S, Murillo SM, Senecal F, Inoue K, Ruiz-Borrego M, Hui R, Denduluri N, Patt D, Rugo HS, Johnston SRD, Bryce R, Zhang B, Xu F, Wong A, Martin M; ExteNET Study Group. Chan A, et al. Among authors: inoue k. Clin Breast Cancer. 2021 Feb;21(1):80-91.e7. doi: 10.1016/j.clbc.2020.09.014. Epub 2020 Oct 6. Clin Breast Cancer. 2021. PMID: 33183970 Free article. Clinical Trial.
Claustrum mediates bidirectional and reversible control of stress-induced anxiety responses.
Niu M, Kasai A, Tanuma M, Seiriki K, Igarashi H, Kuwaki T, Nagayasu K, Miyaji K, Ueno H, Tanabe W, Seo K, Yokoyama R, Ohkubo J, Ago Y, Hayashida M, Inoue KI, Takada M, Yamaguchi S, Nakazawa T, Kaneko S, Okuno H, Yamanaka A, Hashimoto H. Niu M, et al. Among authors: inoue ki. Sci Adv. 2022 Mar 18;8(11):eabi6375. doi: 10.1126/sciadv.abi6375. Epub 2022 Mar 18. Sci Adv. 2022. PMID: 35302853 Free PMC article.
Iron-limitation light switch.
Béjà O, Inoue K. Béjà O, et al. Among authors: inoue k. Nat Microbiol. 2023 Nov;8(11):1942-1943. doi: 10.1038/s41564-023-01491-y. Nat Microbiol. 2023. PMID: 37857820 No abstract available.
Risks of Iodine Excess.
Sohn SY, Inoue K, Rhee CM, Leung AM. Sohn SY, et al. Among authors: inoue k. Endocr Rev. 2024 Nov 22;45(6):858-879. doi: 10.1210/endrev/bnae019. Endocr Rev. 2024. PMID: 38870258 Review.
COVID-19 and Coagulopathy.
Inoue KI, Sagawa T, Takano H. Inoue KI, et al. Am J Respir Cell Mol Biol. 2021 Jun;64(6):764. doi: 10.1165/rcmb.2020-0588LE. Am J Respir Cell Mol Biol. 2021. PMID: 33770450 Free PMC article. No abstract available.
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy.
Chen J, Amoozgar Z, Liu X, Aoki S, Liu Z, Shin SM, Matsui A, Hernandez A, Pu Z, Halvorsen S, Lei PJ, Datta M, Zhu L, Ruan Z, Shi L, Staiculescu D, Inoue K, Munn LL, Fukumura D, Huang P, Sassi S, Bardeesy N, Ho WJ, Jain RK, Duda DG. Chen J, et al. Among authors: inoue k. Cancer Immunol Res. 2024 Apr 2;12(4):400-412. doi: 10.1158/2326-6066.CIR-23-0486. Cancer Immunol Res. 2024. PMID: 38260999 Free PMC article.
Microbial Rhodopsins: The Last Two Decades.
Rozenberg A, Inoue K, Kandori H, Béjà O. Rozenberg A, et al. Among authors: inoue k. Annu Rev Microbiol. 2021 Oct 8;75:427-447. doi: 10.1146/annurev-micro-031721-020452. Epub 2021 Aug 3. Annu Rev Microbiol. 2021. PMID: 34343014 Review.
Rhodopsins at a glance.
Nagata T, Inoue K. Nagata T, et al. Among authors: inoue k. J Cell Sci. 2021 Nov 15;134(22):jcs258989. doi: 10.1242/jcs.258989. Epub 2021 Nov 25. J Cell Sci. 2021. PMID: 34821363
9,943 results